AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Kutscher, EC Lund, BC Hartman, BA
Citation: Ec. Kutscher et al., Peripheral edema associated with mirtazapine, ANN PHARMAC, 35(11), 2001, pp. 1494-1495

Authors: Hatch, CD Lund, BC Perry, PJ
Citation: Cd. Hatch et al., Failed challenge with quetiapine after neuroleptic malignant syndrome withconventional antipsychotics, PHARMACOTHE, 21(8), 2001, pp. 1003-1006

Authors: Lund, BC Neiman, RF
Citation: Bc. Lund et Rf. Neiman, Visual disturbance associated with celecoxib - Author's reply, PHARMACOTHE, 21(8), 2001, pp. 1014-1014

Authors: Carnahan, RM Lund, BC Perry, PJ
Citation: Rm. Carnahan et al., Ziprasidone, a new atypical antipsychotic drug, PHARMACOTHE, 21(6), 2001, pp. 717-730

Authors: Lund, BC Neiman, RF
Citation: Bc. Lund et Rf. Neiman, Visual disturbance associated with celecoxib, PHARMACOTHE, 21(1), 2001, pp. 114-115

Authors: Perry, PJ Lund, BC Sanger, T Besley, C
Citation: Pj. Perry et al., Olanzapine plasma concentrations and clinical response: Acute phase results of the North American Olanzapine Trial, J CL PSYCH, 21(1), 2001, pp. 14-20

Authors: Lund, BC Perry, PJ Brooks, JM Arndt, S
Citation: Bc. Lund et al., Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension - A claims-based approach, ARCH G PSYC, 58(12), 2001, pp. 1172-1176

Authors: Lund, BC Perry, PJ Miller, DD
Citation: Bc. Lund et al., Treating depression in schizophrenia, AM J PSYCHI, 158(9), 2001, pp. 1528-1528

Authors: Lund, BC Bever-Stille, KA Perry, PJ
Citation: Bc. Lund et al., Testosterone and andropause: The feasibility of testosterone replacement therapy in elderly men, PHARMACOTHE, 19(8), 1999, pp. 951-956

Authors: Lund, BC Neiman, RF Perry, PJ
Citation: Bc. Lund et al., Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosis, PHARMACOTHE, 19(12), 1999, pp. 1437-1438

Authors: Lewis, RE Klepser, ME Ernst, EJ Lund, BC Biedenbach, DJ Jones, RN
Citation: Re. Lewis et al., Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection, ANTIM AG CH, 43(8), 1999, pp. 2005-2009
Risultati: 1-11 |